Inventor
MANSOOR UMAR FARUK
US19 patents
⚠️ This page may combine multiple inventors who share the name “MANSOOR UMAR FARUK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
5 patentsUS7504424B2Mar 17, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP24 citations92
US7687527B2Mar 30, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP8 citations84
US7553864B2Jun 30, 2009
Compounds for the treatment of inflammatory disorders and microbial diseases
SCHERING CORP2 citations62
US7998961B2Aug 16, 2011
Hydantoin derivatives useful as antibacterial agents
SCHERING CORP4 citations61
US7638513B2Dec 29, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP6 citations60
MERCK SHARP & DOHME
5 patentsUS9988397B2Jun 5, 2018
ERK inhibitors
MERCK SHARP & DOHME2 citations71
US11312719B2Apr 26, 2022
9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
MERCK SHARP & DOHME4 citations70
US10975084B2Apr 13, 2021
KDM5 inhibitors
MERCK SHARP & DOHME0 citations51
US9233979B2Jan 12, 2016
Compounds that are ERK inhibitors
MERCK SHARP & DOHME0 citations38
US9226922B2Jan 5, 2016
Compounds that are ERK inhibitors
MERCK SHARP & DOHME0 citations38
MERCK SHARP & DOHME LLC
3 patentsUS12263171B2Apr 1, 2025
7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
MERCK SHARP & DOHME LLC2 citations72
US12060357B2Aug 13, 2024
9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
MERCK SHARP & DOHME LLC0 citations59
US12414952B2Sep 16, 2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
MERCK SHARP & DOHME LLC0 citations48